UR-ENERGY INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that UR-ENERGY INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.21M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $33.71M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $17.68M | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | $19.0K | Mar 6, 2024 |
| FY2023 | Dec 31, 2021 | $16.0K | Mar 6, 2024 |
| FY2022 | Dec 31, 2020 | $8.32M | Mar 6, 2023 |
| FY2021 | Dec 31, 2019 | $32.26M | Mar 9, 2022 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $8.32M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $32.26M | Feb 26, 2021 |
| FY2020 | Dec 31, 2018 | $23.50M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $38.37M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $27.31M | Mar 1, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $38.37M | Mar 2, 2018 |
| FY2017 | Dec 31, 2016 | $27.31M | Mar 2, 2018 |
| FY2017 | Dec 31, 2015 | $41.88M | Mar 2, 2018 |
| FY2016 | Dec 31, 2014 | $29.35M | Mar 3, 2017 |
| FY2015 | Dec 31, 2013 | $7.62M | Feb 26, 2016 |
| FY2013 | Dec 31, 2012 | $0 | Mar 3, 2014 |
| FY2013 | Dec 31, 2011 | $0 | Mar 3, 2014 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $74.0K | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | ($8.97M) | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | ($1.69M) | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | ($6.84M) | Mar 6, 2024 |
| FY2023 | Dec 31, 2021 | ($6.98M) | Mar 6, 2024 |
| FY2022 | Dec 31, 2020 | ($4.65M) | Mar 6, 2023 |
| FY2021 | Dec 31, 2019 | $1.98M | Mar 9, 2022 |
| FY2020 | Dec 31, 2018 | $11.29M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $13.97M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $11.46M | Mar 1, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($74.90M) | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | ($53.19M) | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | ($30.66M) | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | ($17.14M) | Mar 6, 2024 |
| FY2023 | Dec 31, 2021 | ($22.94M) | Mar 6, 2024 |
| FY2022 | Dec 31, 2020 | ($14.79M) | Mar 6, 2023 |
| FY2021 | Dec 31, 2019 | ($8.42M) | Mar 9, 2022 |
| FY2020 | Dec 31, 2018 | $4.53M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $76.0K | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | ($3.01M) | Mar 1, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($69.38M) | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | ($63.09M) | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | ($30.84M) | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | ($19.79M) | Mar 6, 2024 |
| FY2023 | Dec 31, 2021 | ($16.76M) | Mar 6, 2024 |
| FY2022 | Dec 31, 2020 | ($13.34M) | Mar 6, 2023 |
| FY2021 | Dec 31, 2019 | ($8.28M) | Mar 9, 2022 |
| FY2020 | Dec 31, 2018 | $1.31M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $1.39M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $271.0K | Mar 1, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2012 | $4.50M | Mar 3, 2014 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($43.13M) | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | ($71.92M) | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | ($16.98M) | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | ($18.09M) | Mar 6, 2024 |
| FY2023 | Dec 31, 2021 | ($11.70M) | Mar 6, 2024 |
| FY2022 | Dec 31, 2020 | ($8.44M) | Mar 6, 2023 |
| FY2021 | Dec 31, 2019 | $3.99M | Mar 9, 2022 |
| FY2020 | Dec 31, 2018 | ($5.36M) | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $5.63M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $3.39M | Mar 1, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.62M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $9.05M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $2.04M | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | $709.0K | Mar 6, 2024 |
| FY2023 | Dec 31, 2021 | $1.19M | Mar 6, 2024 |
| FY2021 | Dec 31, 2020 | $43.0K | Mar 9, 2022 |
| FY2021 | Dec 31, 2019 | $271.0K | Mar 9, 2022 |
| FY2020 | Dec 31, 2018 | ($55.0K) | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $181.0K | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $296.0K | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $272.46M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $194.13M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $128.38M | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | $107.90M | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $120.84M | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | $81.83M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $90.39M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $100.36M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $88.36M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $89.94M | Mar 2, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $46.06M | Feb 28, 2020 |
| FY2019 | Dec 31, 2018 | $48.52M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $49.58M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $53.71M | Mar 2, 2018 |
| FY2016 | Dec 31, 2015 | $63.26M | Mar 3, 2017 |
| FY2015 | Dec 31, 2014 | $71.44M | Feb 26, 2016 |
| FY2014 | Dec 31, 2013 | $66.67M | Mar 2, 2015 |
| FY2013 | Dec 31, 2012 | $3.85M | Mar 3, 2014 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $77.45M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $132.80M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $74.87M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $62.50M | Apr 11, 2025 |
| FY2023 | Dec 31, 2021 | $69.39M | Mar 6, 2024 |
| FY2023 | Dec 31, 2020 | $34.10M | Mar 6, 2024 |
| FY2022 | Dec 31, 2019 | $44.33M | Mar 6, 2023 |
| FY2019 | Dec 31, 2019 | 44.33M | Feb 28, 2020 |
| FY2021 | Dec 31, 2018 | $51.85M | Mar 9, 2022 |
| FY2019 | Dec 31, 2018 | 51.85M | Feb 28, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($379.00M) | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | ($304.10M) | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | ($250.91M) | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | ($220.26M) | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | ($203.12M) | Mar 6, 2023 |
| FY2021 | Dec 31, 2020 | ($180.18M) | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | ($165.39M) | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | ($156.97M) | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | ($161.51M) | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | ($161.58M) | Mar 2, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $123.86M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $76.06M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $59.70M | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | $33.00M | Mar 6, 2024 |
| FY2023 | Dec 31, 2021 | $46.19M | Mar 6, 2024 |
| FY2022 | Dec 31, 2020 | $4.27M | Mar 6, 2023 |
| FY2021 | Dec 31, 2019 | $7.40M | Mar 9, 2022 |
| FY2019 | Dec 31, 2018 | $6.37M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $3.88M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.55M | Mar 2, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $13.34M | Feb 26, 2021 |
| FY2019 | Dec 31, 2019 | $12.44M | Feb 28, 2020 |
| FY2018 | Dec 31, 2018 | $15.00M | Mar 1, 2019 |
| FY2017 | Dec 31, 2017 | $19.89M | Mar 2, 2018 |
| FY2016 | Dec 31, 2016 | $24.51M | Mar 3, 2017 |
| FY2015 | Dec 31, 2015 | $33.19M | Feb 26, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 6, 2024 |
| FY2023 | Dec 31, 2021 | 0 | Mar 6, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 6, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Mar 9, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Feb 26, 2021 |
| FY2018 | Dec 31, 2017 | 0 | Mar 1, 2019 |
| FY2018 | Dec 31, 2016 | 0 | Mar 1, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 6, 2024 |
| FY2023 | Dec 31, 2021 | 0 | Mar 6, 2024 |
| FY2021 | Dec 31, 2020 | 0 | Mar 9, 2022 |
| FY2021 | Dec 31, 2019 | 0 | Mar 9, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Feb 26, 2021 |
| FY2018 | Dec 31, 2017 | 0 | Mar 1, 2019 |
| FY2018 | Dec 31, 2016 | 0 | Mar 1, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 378.17M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | 364.10M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | 270.90M | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | 224.70M | Mar 6, 2024 |
| FY2019 | Dec 31, 2019 | 160.48M | Feb 28, 2020 |
| FY2019 | Dec 31, 2018 | 159.73M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | 146.53M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | 143.68M | Mar 2, 2018 |
| FY2016 | Dec 31, 2015 | 130.19M | Mar 3, 2017 |
| FY2015 | Dec 31, 2014 | 129.37M | Feb 26, 2016 |